Phio Pharmaceuticals names dermatologist R. Todd Plott to board
PHIO•Board appointment adds dermatology expertise
Phio Pharmaceuticals appointed R. Todd Plott to its board on Jul. 21, 2026.
Plott is a board-certified dermatologist with more than 30 years in patient care, dermatologic research, and drug development. He oversaw hundreds of clinical trials, holds inventor credentials, and served on the FDA Dermatologic and Ophthalmic Drug Advisory Committee from 2016 to 2021.
The appointment adds dermatology and clinical development expertise as Phio advances PH-762 in skin cancers, including cutaneous squamous cell carcinoma.
